Less than 30% of CBD products are accurately labeled. IAMA neuroscientist using third party, independent lab testing to find high-quality CBD products. Let’s chat about what CBD is good for, what it’s not good for, and everything in between. AMA.
What is CBD? Will CBD get me high? Is CBD addictive? How much CBD do I take? What is CBD good for? I answer these questions among others every day.
The CBD market has exploded. With the CBD boom, snake oil merchants armed with misinformation and lack of regulation have saturated the market of the popular cannabinoid. It can be confusing or even scary for people to find legitimate information and products. Not everyone knows that there are a lot of poor quality CBD products in the market. A 2017 study published in JAMA suggests only about 30% of CBD products are labeled accurately. We have done our own 3rd party blind testing on close to 400 products and only about 20% have been labeled accurately, meaning they failed for being within 10%+/- of the labeled amount of cannabinoids, had ingredients they shouldn’t have, or didn’t have ingredients they claimed to have.
Some people know a lot about CBD and other related compounds, but there are many people who still have basic questions. After presenting and getting some great questions during a CBD panel at the AZ Plant Medicine Conference, we thought we could share in the holiday spirit of giving to disseminate quality information to the community. I am Austin Flohrschutz AMA about CBD!
My education: BS in Behavioral Neuroscience and MS in Neuroscience (recently decided to leave a PhD program in Neuroscience with an MS degree to become Director of Science for a science-led CBD company). As an undergraduate, I worked in a medicinal chemistry lab focused on extracting biologically active compounds from plants (Salvia divinorum), which were then purified and used to synthesize new potential drugs to treat pain without addictive properties. While in graduate school I worked in a neuropharmacology lab focused on pain, opioids, addiction, and cannabinoids. At my current organization we formed a board of some pre-eminent cannabinoid researchers who sit on our Science Advisory Board that I collaborate with, including:
Todd Vanderah, PhD in Pharmacology - Head and Professor of Pharmacology, and is a Professor in the Departments of Neurology and Anesthesiology at The University of Arizona, College of Medicine. His research interests include mechanisms of cancer pain, neuronal integration in pain pathways, neurochemical release during conditions of neuropathy, neuronal plasticity, addiction, cannabinoid & opioid receptor pharmacology, as well as the discovery of novel targets for new medications.
Adam Friedman, MD, FAAD is Professor and Interim Chair of Dermatology and serves as Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the Department of Dermatology at The George Washington University School of Medicine & Health Sciences. Dr. Friedman is investigating novel nanotechnologies that allow for advanced delivery of a wide spectrum of medicinally relevant molecules, such as cannabinoids, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation, and correcting vascular dysfunction.
Dr. Hope Jones is Chief Scientific Officer of Emergent Cannabis Sciences -- an advising company driving scientific innovation within the cannabis industry -- and CEO and founder of Adivina Crop Science -- offering state of the art cannabis tissue culture and micropropagation services. Dr. Jones' previously worked as a Staff Scientist for NASA’s Life Sciences and Biosystems Engineering Program, where she was responsible for micropropagation production of crops, phytochemical research, and developing growing system technologies for deep space missions.
Note: Our science advisory board is currently busy today with work and teaching, so they will help answer questions over the next 24 hours or so through this shared account.
The company I work for is called TruPotency.com. I and the other science advisors joined this company because we’re philosophically aligned with their mission of blind 3rd party testing every product to ensure they’re properly labeled and safe for use. We also upload our lab results to every product page. Lastly, we display cannabinoid and terpene profiles on every product page in an easy way to digest. We sincerely hope you find this useful.
IMPORTANT FDA DISCLAIMER: The statements made regarding CBD products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. CBD products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not meant to substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.
EDIT: This thread is getting quite long. I will do my best to keep answering questions throughout the day and tomorrow.
EDIT 2: Signing off for now. Will answer a few questions later tonight and hop back on in the morning. Thank you, everyone, for the great discussion! I hope there is some good information for y'all.
EDIT 3: Thank you all for a great AMA! To our surprise and delight, this exploded much bigger than we ever thought it would. We hope you all find helpful information in this thread. Although there was much more than we could get to in the last two days, please contact us at [email protected] for further communication.